基于HIS系统的16 059例脑梗死患者使用疏血通注射液的现状分析(4)
2.School of Statistics， Renmin University of China， Beijing 100872， China；
3.The PLA Navy General Hospital， Beijing 100048， China)
[Abstract] Objective： Hospital information system data of cerebral infaction patients who received parenterally administered Shuxuetong was analyzed. This provided frequency data regarding patients′ conditions and related information in order to provide a clinical reference guide. Method： In this study， HIS data from 18 hospitals was analyzed. Patients receiving parenterally administered Shuxuetong for the treatment of cerebral infarction were included. Information on age， gender， costsand route of administration were collated. Result： The average age of patients was 66 years old. Days of hospitalization ranged from 15 to 28 days. The majority of patients were classified as having phlegm and blood stasis syndrome， which is inaccordance with the indications for this drug. The most commonly used drugs used in combination with parenterally administered Shuxuetong were： aspirin， insulin and heparin. Conclusion： Patients with cerebral infarction crowd using parenterally administered Shuxuetong were a mostly elderly population， with an average age of 66. Although generally use was in accordance with indications， dosage， and route of administration， there were however some discrepancies. Therefore， doctors need to pay close attention to guidelines and closely observe patients when using parenterally administered Shuxuetong and to consider both the clinical benefits and risks.
[Key words] hospital information system； parenterally administered Shuxuetong； cerebral infarction
doi：10.4268/cjcmm20131835, 百拇医药(支英杰 张辉 谢雁鸣 杨伟 杨虎 庄严)
3.The PLA Navy General Hospital， Beijing 100048， China)
[Abstract] Objective： Hospital information system data of cerebral infaction patients who received parenterally administered Shuxuetong was analyzed. This provided frequency data regarding patients′ conditions and related information in order to provide a clinical reference guide. Method： In this study， HIS data from 18 hospitals was analyzed. Patients receiving parenterally administered Shuxuetong for the treatment of cerebral infarction were included. Information on age， gender， costsand route of administration were collated. Result： The average age of patients was 66 years old. Days of hospitalization ranged from 15 to 28 days. The majority of patients were classified as having phlegm and blood stasis syndrome， which is inaccordance with the indications for this drug. The most commonly used drugs used in combination with parenterally administered Shuxuetong were： aspirin， insulin and heparin. Conclusion： Patients with cerebral infarction crowd using parenterally administered Shuxuetong were a mostly elderly population， with an average age of 66. Although generally use was in accordance with indications， dosage， and route of administration， there were however some discrepancies. Therefore， doctors need to pay close attention to guidelines and closely observe patients when using parenterally administered Shuxuetong and to consider both the clinical benefits and risks.
[Key words] hospital information system； parenterally administered Shuxuetong； cerebral infarction
doi：10.4268/cjcmm20131835, 百拇医药(支英杰 张辉 谢雁鸣 杨伟 杨虎 庄严)